The launch of Heme Libra, a 28-day hemophilia treatment, revealed a key challenge: patients accustomed to daily infusions were scared to trust the new, infrequent therapy. This shows that marketing truly disruptive products requires building trust and overcoming ingrained user habits, going beyond just demonstrating clinical superiority.

To maintain trust, AI in medical communications must be subordinate to human judgment. The ultimate guardrail is remembering that healthcare decisions are made by people, for people. AI should assist, not replace, the human communicator to prevent algorithmic control over healthcare choices.

Initial public fear over new technologies like AI therapy, while seemingly negative, is actually productive. It creates the social and political pressure needed to establish essential safety guardrails and regulations, ultimately leading to safer long-term adoption.

To overcome resistance, AI in healthcare must be positioned as a tool that enhances, not replaces, the physician. The system provides a data-driven playbook of treatment options, but the final, nuanced decision rightfully remains with the doctor, fostering trust and adoption.

The current AI narrative often removes human agency, creating fear. Reframing AI's capabilities as tools that empower people—much like how Steve Jobs pitched personal computers—can make the technology more inspiring and less threatening to the general public, fostering wider acceptance.

Rather than hiding unsettling medical realities like tissue procurement, being transparent can demystify the process and build public trust. Acting secretive makes people assume there is something to hide, whereas openly explaining even 'gruesome' details can reassure the public and ultimately help an organization's mission, such as encouraging organ donation.

Patients often feel like "guinea pigs" and view informed consent forms as irreversible contracts, creating a major barrier to clinical trial enrollment. To counter this, clinicians should stress that patient safety is the top priority, all trials undergo ethical review, and participation can be stopped by the patient at any time without penalty.

The biotech industry's messaging to legislators often fails because it focuses on economic contributions. To gain support and combat negative narratives, leaders must shift to "plain speak," using patient stories to humanize their work and focus on their core mission of improving health.

Public resistance to frontier tech like AI and genetics is driven by abstract sci-fi narratives. The most effective antidote is direct product experience. Using ChatGPT makes 'Terminator' seem ridiculous, just as seeing embryo selection software demystifies the 'Gattaca' narrative.